You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 105 No. 10, October 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  CORRESPONDENCE
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Bulbar Conjunctival Defects Associated With Gentamicin

Richard Nauheim, MD; Jack Nauheim, MD
Merrick, NY

Arch Ophthalmol. 1987;105(10):1321.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—It is well established that topical gentamicin can cause toxic reactions. The findings include punctate staining of the cornea and conjunctiva, mucopurulent discharge, conjunctival hyperemia, and mild papillary hypertrophy. Withdrawal of the offending agent results in resolution of the reaction.

We have recently observed six patients who developed conjunctival defects while using topical gentamicin in either the solution or ointment form. The antibiotic or its preservatives induced the observed pathologic conditions. To our knowledge, this manifestation of topical gentamicin toxicity has not been previously reported.

The characteristic appearance of this reaction is a focal area of bulbar conjunctival hyperemia that stains with fluorescein. The lesions are pleomorphic in shape and variable in location, although most were observed in the inferior half of the globe (Fig 1). The conjunctival defects developed within five days of institution of therapy with topical gentamicin ophthalmic solution or ointment and resolved within . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.